On November 18, 3SBIO fell 4.11% in Regular Trading, trading at HK$13.28, with turnover of HK$50.37 million.
The clearest recent catalyst is a disclosed BlackRock position reduction. BlackRock disposed of 6.29 million 3SBIO shares on November 12 through an off-exchange transaction, and its long position ratio declined from 6.23% to 5.98%, moving below the 6% level. The filing stated the consideration involved non-cash assets and the trade was not matched on the SEHK open market, meaning it was not a direct secondary-market sale.
Earlier company filings showed 3SBIO repurchased 6.3375 million shares during October 8 to 14 at HK$14.40 to HK$15.59 per share and held them as treasury shares, yet the stock remained under pressure afterward, limiting the supportive effect of buybacks on sentiment.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments